Advertisement
Screener

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price

2.0 / 5 stars · 19/47 Roast Me

PROVECTUS BIOPHARMACEUTICALS, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $0.24 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-03-26

  • PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2025 was $0.24, a 72.73% decline from fiscal 2024.
  • PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $0.88, a 31.34% increase from fiscal 2023.
  • PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $0.67, a 22.09% decline from fiscal 2022.
  • PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2022 was $0.86, a 3.37% decline from fiscal 2021.
Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month
2025-12-31$0.24
10-K · filed 2026-03-26
2024-12-31$0.88
10-K · filed 2025-03-28
2023-12-31$0.67
10-K · filed 2025-03-28
2023-09-30$0.67
10-Q · filed 2023-11-14
2022-12-31$0.86
10-K · filed 2024-03-28
2022-09-30$0.86
10-Q · filed 2022-11-09
2021-12-31$0.89
10-K · filed 2023-03-30
2021-09-30$0.98
10-Q · filed 2021-11-10
2020-12-31$0.88
10-K · filed 2022-03-29
2019-12-31$0.88
10-K · filed 2021-03-02
2018-12-31$0.89
10-K · filed 2020-03-05
2017-12-31$0.90
10-K · filed 2018-03-23
2016-12-31$0.97
10-K · filed 2018-03-23